BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22113063)

  • 1. Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction.
    Lofthus DM; Stevens SR; Armstrong PW; Granger CB; Mahaffey KW
    Coron Artery Dis; 2012 Jan; 23(1):22-30. PubMed ID: 22113063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
    Leonardi S; Thomas L; Neely ML; Tricoci P; Lopes RD; White HD; Armstrong PW; Giugliano RP; Antman EM; Califf RM; Newby LK; Mahaffey KW
    J Am Coll Cardiol; 2012 Dec; 60(22):2296-304. PubMed ID: 23122801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
    Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
    J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
    Galla JM; Mahaffey KW; Sapp SK; Alexander JH; Roe MT; Ohman EM; Granger CB; Armstrong PW; Harrington RA; White HD; Simoons ML; Newby LK; Califf RM; Topol EJ
    Am Heart J; 2006 Jan; 151(1):16-24. PubMed ID: 16368286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Bagai A; Schulte PJ; Granger CB; Mahaffey KW; Christenson RH; Bell G; Lopes RD; Green CL; Lincoff AM; Armstrong PW; Roe MT
    Am Heart J; 2014 Oct; 168(4):503-511.e2. PubMed ID: 25262260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
    Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
    Mahaffey KW; Roe MT; Kilaru R; Alexander JH; Van de Werf F; Califf RM; Simoons ML; Topol EJ; Harrington RA
    Eur Heart J; 2007 Feb; 28(4):425-32. PubMed ID: 17267458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
    Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis.
    Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Cho KI; Kim BH; Je HG; Park YH
    Catheter Cardiovasc Interv; 2013 May; 81(6):959-67. PubMed ID: 22744792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy.
    Lopes RD; Lokhnygina Y; Hasselblad V; Newby KL; Yow E; Granger CB; Armstrong PW; Hochman JS; Mills JS; Ruzyllo W; Mahaffey KW
    Trials; 2013 May; 14():123. PubMed ID: 23782531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification and diagnosis of myocardial damage and acute myocardial infarction during cardiopulmonary resuscitation].
    Wang JG; Kong DQ; Huang Y; Huang JY; Zhang ZL; Wu WC; Pan XW
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jun; 21(6):333-6. PubMed ID: 19570336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
    Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
    Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; van 't Hof AW
    Coron Artery Dis; 2009 Jan; 20(1):9-14. PubMed ID: 19050596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of myoglobin to predict mortality in patients admitted for exclusion of myocardial infarction.
    Kontos MC; Garg R; Anderson FP; Roberts CS; Ornato JP; Tatum JL; Jesse RL
    Am J Emerg Med; 2007 Oct; 25(8):873-9. PubMed ID: 17920970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.
    Di Chiara A; Dall'Armellina E; Badano LP; Meduri S; Pezzutto N; Fioretti PM
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):587-92. PubMed ID: 20588136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients.
    Vikenes K; Melberg T; Farstad M; Nordrehaug JE
    Scand Cardiovasc J; 2010 Apr; 44(2):69-75. PubMed ID: 19670037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.
    Srinivas VS; Cannon CP; Gibson CM; Antman EM; Greenberg MA; Tanasijevic MJ; Murphy S; de Lemos JA; Sokol S; Braunwald E; Mueller HS
    Am Heart J; 2001 Jul; 142(1):29-36. PubMed ID: 11431653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.